A Long-term Extension Study of PCI-32765 (Ibrutinib)

NCT ID: NCT01804686

This clinical trial is focused on studying the long-term safety and effectiveness of a medication called ibrutinib for patients with various types of blood cancers, including chronic lymphocytic le...

Recruiting

Phase: PHASE3 Type: interventional Locations: Lebanon, New Hampshire, United States, Charlottesville, Virginia, United States +203 more

HM2023-43:Ph 2 Trial of Tafasitamab With Lenalidomide+Rituximab in Treatment-naive FL and MZL

NCT ID: NCT06792825

This clinical trial, called HM2023-43, is studying a new treatment combination for patients with two types of lymphoma: follicular lymphoma (FL) and marginal zone lymphoma (MZL). The researchers wa...

Not yet recruiting

Phase: PHASE2 Type: interventional

A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006)

NCT ID: NCT05458297

This clinical trial is studying a new treatment called zilovertamab vedotin for patients with certain types of B-cell lymphomas, including chronic lymphocytic leukemia (CLL), mantle cell lymphoma (...

Recruiting

Phase: PHASE2 Type: interventional Locations: Seoul, , Korea, Republic Of, Warszawa, Mazowieckie, Poland +159 more

Comparison Between Local Radiotherapy Alone or Combined With Obinutuzumab in Early Stage Follicular Lymphoma: the GAZEBO Trial From the Fondazione Italiana Linfomi

NCT ID: NCT05929222

The GAZEBO Trial is a study designed to compare two treatment options for patients with early-stage Follicular Lymphoma, a type of blood cancer. Specifically, researchers want to see if adding a me...

Recruiting

Phase: PHASE3 Type: interventional Locations: Milano, , Italy, Alessandria, , Italy +46 more

Evaluation of Skin Tests in Biotherapy Allergies

NCT ID: NCT06971848

This clinical trial, titled "Evaluation of Skin Tests in Biotherapy Allergies," is studying how to better identify allergic reactions in patients receiving certain biotherapy treatments. Biotherapi...

Not yet recruiting

Phase: NA Type: interventional Locations: Angers, , France

Clonal Evolution in Follicular Lymphoma

NCT ID: NCT03190928

This clinical trial is studying follicular lymphoma, a type of cancer that affects the lymph nodes. The researchers aim to collect different samples from patients with follicular lymphoma to better...

Recruiting

Type: observational Locations: Bethesda, Maryland, United States

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

NCT ID: NCT06131801

This clinical trial is studying how well venetoclax, a medication used to treat certain types of blood cancers like leukemia and lymphoma, works when the tablets are crushed and dissolved in liquid...

Recruiting

Type: observational Locations: Cincinnati, Ohio, United States

A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma (GOLSEEK-4)

NCT ID: NCT06911502

The GOLSEEK-4 trial is a clinical study designed to compare the effectiveness and safety of a new treatment called golcadomide combined with rituximab against the current best treatment options for...

Not yet recruiting

Phase: PHASE3 Type: interventional Locations: Beijing, Beijing, China, Nanchang, Jiangxi, China +174 more

Epcoritamab and Rituximab for First-line Follicular Lymphoma

NCT ID: NCT05783609

This clinical trial is studying a combination of two medications, rituximab and epcoritamab, to see how effective and safe they are for treating patients with Follicular Lymphoma (FL) who have not ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Milwaukee, Wisconsin, United States, Rochester, New York, United States +2 more

A Phase 2 Study of Epcoritamab, Zanubrutinib, and Rituximab (EZR) for Treatment of Relapsed or Refractory Follicular Lymphoma or Marginal Zone Lymphoma

NCT ID: NCT06563596

This clinical trial is studying a combination of three medications—epcoritamab, zanubrutinib, and rituximab— to see how well they work together in treating patients with relapsed or refractory foll...

Recruiting

Phase: PHASE2 Type: interventional Locations: Boston, Massachusetts, United States, Boston, Massachusetts, United States

Allo HSCT Using RIC and PTCy for Hematological Diseases

NCT ID: NCT05805605

This clinical trial is looking at a new approach to treating certain blood cancers, including various types of leukemia and lymphoma. The study is specifically evaluating a method called "Allo HSCT...

Recruiting

Phase: PHASE2 Type: interventional Locations: Minneapolis, Minnesota, United States

Shortened vs Standard Chemotherapy Combined With Immunotherapy for the Initial Treatment of Patients With High Tumor Burden Follicular Lymphoma

NCT ID: NCT05058404

This clinical trial, called FIL_FOLL19, is studying a new approach to treating patients with high tumor burden follicular lymphoma, a type of blood cancer. The main goal is to see if giving fewer c...

Recruiting

Phase: PHASE3 Type: interventional Locations: Roma, , Italy, Pavia, , Italy +75 more

Prospective Biological Study to Evaluate the Persistence of COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in Follicular Lymphoma Patients Undergoing Frontline Induction Immuno-chemotherapy and Anti-CD20 Maintenance

NCT ID: NCT06070961

This clinical trial is studying how long the immune response from COVID-19 vaccines and other vaccines (like those for shingles, diphtheria, and tetanus) lasts in patients with Follicular Lymphoma ...

Recruiting

Type: observational Locations: Firenze, , Italy, Reggio Emilia, , Italy +13 more

Combating Cancer-Related Fatigue: A Personalized Supportive Care Program

NCT ID: NCT06860880

This clinical trial, titled "Combating Cancer-Related Fatigue: A Personalized Supportive Care Program," is designed to help patients with certain types of indolent lymphomas, including chronic lymp...

Recruiting

Phase: NA Type: interventional Locations: Chapel Hill, North Carolina, United States

A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)

NCT ID: NCT05512390

This clinical trial is studying a new treatment called ABBV-319 for adults with certain types of blood cancers, specifically relapsed or refractory diffuse large B-cell lymphoma (DLBCL), follicular...

Recruiting

Phase: PHASE1 Type: interventional Locations: New Haven, Connecticut, United States, Worcester, Massachusetts, United States +23 more

A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies

NCT ID: NCT05006716

This clinical trial is studying a new treatment called BGB-16673 for patients with specific types of B-cell cancers, such as Marginal Zone Lymphoma, Follicular Lymphoma, and Chronic Lymphocytic Leu...

Recruiting

Phase: PHASE1 Type: interventional Locations: New York, New York, United States, Rochester, Minnesota, United States +197 more

A Study of Reduced Dose Radiation Therapy for People With B-Cell Lymphomas

NCT ID: NCT07029217

This clinical trial is studying whether a very low dose of radiation therapy (called VLDRT) can effectively treat people with certain types of slow-growing blood cancers called follicular lymphoma ...

Recruiting

Phase: PHASE3 Type: interventional Locations: New York, New York, United States, Harrison, New York, United States +5 more

Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders

NCT ID: NCT03314974

This clinical trial is studying a type of treatment called allogeneic hematopoietic stem cell transplant (HCT) for patients with various blood cancers, including leukemia and lymphoma. The aim is t...

Recruiting

Phase: PHASE2 Type: interventional Locations: Minneapolis, Minnesota, United States

A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma.

NCT ID: NCT04224493

This clinical trial is testing a new treatment combination for adults with relapsed or refractory follicular lymphoma, a type of blood cancer that has returned or is resistant to previous therapies...

Recruiting

Phase: PHASE3 Type: interventional Locations: Ann Arbor, Michigan, United States, Chicago, Illinois, United States +311 more

A Study of AZD0486 in Subjects With B-Cell Non-Hodgkin Lymphoma

NCT ID: NCT04594642

This clinical trial is testing a new treatment called AZD0486 for patients with certain types of B-cell non-Hodgkin lymphoma (B-NHL), which is a type of cancer that affects the lymphatic system. Sp...

Recruiting

Phase: PHASE1 Type: interventional Locations: Milwaukee, Wisconsin, United States, Tampa, Florida, United States +30 more

Main Menu

Clinical Trials for Follicular Lymphoma

96 Active Trials Found

A Long-term Extension Study of PCI-32765 (Ibrutinib)

HM2023-43:Ph 2 Trial of Tafasitamab With Lenalidomide+Rituximab in Treatment-naive FL and MZL

A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006)

Comparison Between Local Radiotherapy Alone or Combined With Obinutuzumab in Early Stage Follicular Lymphoma: the GAZEBO Trial From the Fondazione Italiana Linfomi

Evaluation of Skin Tests in Biotherapy Allergies

Clonal Evolution in Follicular Lymphoma

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma (GOLSEEK-4)

Epcoritamab and Rituximab for First-line Follicular Lymphoma

A Phase 2 Study of Epcoritamab, Zanubrutinib, and Rituximab (EZR) for Treatment of Relapsed or Refractory Follicular Lymphoma or Marginal Zone Lymphoma

Allo HSCT Using RIC and PTCy for Hematological Diseases

Shortened vs Standard Chemotherapy Combined With Immunotherapy for the Initial Treatment of Patients With High Tumor Burden Follicular Lymphoma

Prospective Biological Study to Evaluate the Persistence of COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in Follicular Lymphoma Patients Undergoing Frontline Induction Immuno-chemotherapy and Anti-CD20 Maintenance

Combating Cancer-Related Fatigue: A Personalized Supportive Care Program

A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)

A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies

A Study of Reduced Dose Radiation Therapy for People With B-Cell Lymphomas

Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders

A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma.

A Study of AZD0486 in Subjects With B-Cell Non-Hodgkin Lymphoma

Related Conditions